Dr. Thomas Geoffrey Folk, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 306 Westwood Ave, Suite 401, High Point, NC 27262 Phone: 336-885-6168 Fax: 336-885-6402 |
Warren G. Gallemore, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 810 N Lindsay St, High Point, NC 27262 Phone: 336-802-2060 Fax: 336-802-2061 |
Richard Lowman Orr, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1814 Westchester Dr, Suite 301, High Point, NC 27262 Phone: 336-802-2025 Fax: 336-802-2026 |
Clifford Daniel Hendrickson, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 University Pkwy, High Point, NC 27268 Phone: 336-841-4683 Fax: 336-888-6353 |
Basavatti Madappa Sowmya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 N Elm St, High Point, NC 27262 Phone: 319-368-5970 Fax: 319-368-5973 |
News Archive
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
States that ran their own insurance marketplaces under the health law or those that partnered with the federal government spent significantly more on outreach and enrollment efforts than states that used the federal marketplace, according to a study funded by the Robert Wood Johnson Foundation.
After gobbling the fourth Oreo in a row while bathed in refrigerator light, have you ever thought, "That wasn't enough," and then proceeded to search for something more? Researchers at BYU have shed new light on why you, your friends, neighbors and most everyone you know tend to snack at night: some areas of the brain don't get the same "food high" in the evening.
Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
› Verified 2 days ago